Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06295731
Title INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS>=20 HNSCC (HexAgon-HN)
Acronym HexAgon-HN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Inhibrx Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center RECRUITING Duarte California 91010 United States Details
Mid Florida Hematology and Oncology Center RECRUITING Orange City Florida 32763 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Washington University St. Louis RECRUITING Saint Louis Missouri 63110 United States Details
Oncology Hematology West, PC dba Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Christus St. Vincent Regional Cancer Center RECRUITING Santa Fe New Mexico 87505 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field